Untargeted metabolomics yields insight into ALS disease mechanisms.

For Public Health

Key points

Investigate metabolomic pathways associated with the development and treatment of ALS

Affiliates

Stephen A Goutman [1], Jonathan Boss [2], Kai Guo [3], Fadhl M Alakwaa [1], Adam Patterson [1], Sehee Kim [2], Masha Georges Savelieff [1], Junguk Hur [3], Eva L Feldman [1]

  1. Department of Neurology, University of Michigan
  2. Department of Biostatistics, University of Michigan
  3. Department of Biomedical Sciences, University of North Dakota

Journal

Neuromuscular

Summary

Understanding dysregulated metabolic pathways in amyotrophic lateral sclerosis (ALS) is important in discovering important therapeutic targets. This study located important metabolic pathway alterations with known pathomechanisms, or pathways to developing said disease, to ALS.

Link to paper

Find the paper here!

Print
Content Source
Agency for Toxic Substances and Disease Registry
About This Page
Published: November 12, 2024
Updated: November 11, 2024

This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.

Reviewed: September 10, 2026

The information on this page was last reviewed by subject matter experts to ensure accuracy.